display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
mBC - TNBC - L1 - all populationmBC - TNBC - L1 - PDL1 positivemBC - TNBC - L2 - all populationmBC - TNBC - L2 - PDL1 positivees-BC - TNBC - NA - all population
pembrolizumab based treatment
pembrolizumab alone KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-522
pembrolizumab plus SoC KEYNOTE-355 ... KEYNOTE-355 ... KEYNOTE-355 ...

Study type: